96 related articles for article (PubMed ID: 20596057)
1. Addition of adenoviral vector targeting of chemotherapy to the MUC-1/ecdCD40L VPPP vector prime protein boost vaccine prolongs survival of mice carrying growing subcutaneous deposits of Lewis lung cancer cells.
Akbulut H; Tang Y; Akbulut KG; Maynard J; Deisseroth A
Gene Ther; 2010 Nov; 17(11):1333-40. PubMed ID: 20596057
[TBL] [Abstract][Full Text] [Related]
2. An adenoviral vector cancer vaccine that delivers a tumor-associated antigen/CD40-ligand fusion protein to dendritic cells.
Zhang L; Tang Y; Akbulut H; Zelterman D; Linton PJ; Deisseroth AB
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15101-6. PubMed ID: 14645711
[TBL] [Abstract][Full Text] [Related]
3. Antitumor immune response induced by i.t. injection of vector-activated dendritic cells and chemotherapy suppresses metastatic breast cancer.
Akbulut H; Tang Y; Akbulut KG; Maynard J; Zhang L; Deisseroth A
Mol Cancer Ther; 2006 Aug; 5(8):1975-85. PubMed ID: 16928818
[TBL] [Abstract][Full Text] [Related]
4. Vector prime/protein boost vaccine that overcomes defects acquired during aging and cancer.
Tang Y; Akbulut H; Maynard J; Petersen L; Fang X; Zhang WW; Xia X; Koziol J; Linton PJ; Deisseroth A
J Immunol; 2006 Oct; 177(8):5697-707. PubMed ID: 17015759
[TBL] [Abstract][Full Text] [Related]
5. [The anti-tumor activity of GM-CSF-modified lung cancer cell vaccine and its synergism in combination with chemotherapy].
Jiang HJ; Ren XB; Li H; Yu JP; Wei F; Ma MQ
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):808-12. PubMed ID: 18396635
[TBL] [Abstract][Full Text] [Related]
6. TAA/ecdCD40L adenoviral prime-protein boost vaccine for cancer and infectious diseases.
Deisseroth A; Tang Y; Zhang L; Akbulut H; Habib N
Cancer Gene Ther; 2013 Feb; 20(2):65-9. PubMed ID: 23238593
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
Akbulut H; Zhang L; Tang Y; Deisseroth A
Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of GM-CSF-producing tumor vaccine after docetaxel chemotherapy in mice bearing established Lewis lung carcinoma.
Chu Y; Wang LX; Yang G; Ross HJ; Urba WJ; Prell R; Jooss K; Xiong S; Hu HM
J Immunother; 2006; 29(4):367-80. PubMed ID: 16799332
[TBL] [Abstract][Full Text] [Related]
9. Multistep process through which adenoviral vector vaccine overcomes anergy to tumor-associated antigens.
Tang Y; Zhang L; Yuan J; Akbulut H; Maynard J; Linton PJ; Deisseroth A
Blood; 2004 Nov; 104(9):2704-13. PubMed ID: 15238426
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy targeted to cancer tissue potentiates antigen-specific immune response induced by vaccine for in vivo antigen loading and activation of dendritic cells.
Akbulut H; Tang Y; Akbulut KG; Maynard J; Deisseroth A
Mol Ther; 2008 Oct; 16(10):1753-60. PubMed ID: 18728641
[TBL] [Abstract][Full Text] [Related]
11. Administration of vitamin D3 improves antimetastatic efficacy of cancer vaccine therapy of Lewis lung carcinoma.
Zhuravel E; Efanova O; Shestakova T; Glushko N; Mezhuev O; Soldatkina M; Pogrebnoy P
Exp Oncol; 2010 Mar; 32(1):33-9. PubMed ID: 20332759
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of murine bone marrow-derived dendritic cells infected with xenogeneic livin alpha recombinant adenoviral vectors against Lewis lung carcinoma.
Xie J; Xiong L; Tao X; Li X; Su Y; Hou X; Shi H
Lung Cancer; 2010 Jun; 68(3):338-45. PubMed ID: 19671483
[TBL] [Abstract][Full Text] [Related]
13. [Gene transfer of murine Flt3 ligand mediated by adenoviral vector efficiently induces growth inhibition of murine liver cancer].
Yang Q; Yang G; Wei L; Jia F; Wu M; Guo Y
Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):775-9. PubMed ID: 12126551
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effect of adenoviral vector prime protein boost immunity targeting the MUC1 VNTRs.
Wang Y; Liu C; Xia Q; Wang P; Li B; Lu Z; Sun J; Wu H; Yu B; Wu J; Yu X; Kong W; Zhang H; Cong X
Oncol Rep; 2014 Mar; 31(3):1437-44. PubMed ID: 24378623
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitory effect of adenovirus-mediated endostatin gene transfer on transplanted lung carcinoma in mice].
Sui G; Xu ZF; Sun YC; Liu YJ; Wu LH; Qin X
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):93-6. PubMed ID: 18646688
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.
Ji L; Fang B; Yen N; Fong K; Minna JD; Roth JA
Cancer Res; 1999 Jul; 59(14):3333-9. PubMed ID: 10416589
[TBL] [Abstract][Full Text] [Related]
18. Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model.
Tillman BW; Hayes TL; DeGruijl TD; Douglas JT; Curiel DT
Cancer Res; 2000 Oct; 60(19):5456-63. PubMed ID: 11034088
[TBL] [Abstract][Full Text] [Related]
19. alpha-Tocopheryl succinate sensitizes established tumors to vaccination with nonmatured dendritic cells.
Ramanathapuram LV; Kobie JJ; Bearss D; Payne CM; Trevor KT; Akporiaye ET
Cancer Immunol Immunother; 2004 Jul; 53(7):580-8. PubMed ID: 14991239
[TBL] [Abstract][Full Text] [Related]
20. Experimental study of the efficacy of combined use of cancer vaccine and interferon.
Potebnya GP; Kudryavets YY; Lisovenko GS; Cheremshenko NL; Voeykova IM; Trokhimenko NV; Symchich TV; Evstrateyva LM
Exp Oncol; 2007 Jun; 29(2):102-5. PubMed ID: 17704740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
